| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ORIGINAL ARTICLES |
From the Departments of Surgical Oncology (SAV, YL, XL, KKH) and Thoracic and Cardiovascular Surgery (AP, SGS), University of Texas, M. D. Anderson Cancer Center, Houston, Texas; and the Department of Surgery (KY), Jikei University School of Medicine, Tokyo, Japan.
Correspondence: Address correspondence and reprint requests to: Kelly K. Hunt, MD, FACS, Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 444, Houston, TX 77030; Fax: 713-792-4689; E-mail: khunt{at}mdanderson.org
Background: Overexpression of the transcription factor E2F-1 provokes apoptosis in cancer cells; the mechanism, however, is not completely understood. We sought to evaluate E2F-1 gene therapy in human colon cancer and to investigate the apoptotic pathway involved.
Methods: Adenoviral vectors were used to transfect the E2F-1 gene (Ad5E2F-1) or the control gene luciferase (Ad5Luc) into four human colon carcinoma cell lines. Apoptosis was confirmed by flow cytometry and poly (ADP-ribose) polymerase cleavage. Expression of apoptotic factors was determined with Western blot analysis. Inhibitory assays were used to determine the involvement of caspases in the apoptotic pathway.
Results: Overexpression of E2F-1 was evident in all cells treated with Ad5E2F-1; upregulation of Bcl-2, and activation of caspases were noted. The apoptosis-inducing factor in the cytosolic fraction was markedly upregulated after Ad5E2F-1 treatment. E2F-1 overexpression inhibited proliferation and induced significant apoptosis in all cell lines (P < .005). This apoptotic response could be only partially blocked by caspase inhibitors.
Conclusions: These findings demonstrate that E2F-1 induces apoptosis and inhibits proliferation in human colon cancer cell lines. The marked upregulation of apoptosis-inducing factor and the fact that E2F-1induced apoptosis is incompletely blocked by caspase inhibitors suggest a caspase-independent pathway of E2F-1mediated apoptosis, reported here for the first time.
Key Words: Apoptosis E2F-1 Colon cancer Apoptosis-inducing factor Mitochondrion
This article has been cited by other articles:
![]() |
W. Xie, P. Jiang, L. Miao, Y. Zhao, Z. Zhimin, L. Qing, W.-g. Zhu, and M. Wu Novel link between E2F1 and Smac/DIABLO: proapoptotic Smac/DIABLO is transcriptionally upregulated by E2F1. Nucleic Acids Res., January 1, 2006; 34(7): 2046 - 2055. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Vorburger, N. Hetrakul, W. Xia, M. Wilson-Heiner, N. Mirza, R. E. Pollock, B. Feig, S. G. Swisher, and K. K. Hunt Gene therapy with E2F-1 up-regulates the protein kinase PKR and inhibits growth of leiomyosarcoma in vivo Mol. Cancer Ther., November 1, 2005; 4(11): 1710 - 1716. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Li, J. Stanelle, C. Leurs, H. Hanenberg, and B. M. Putzer Selection of novel mediators of E2F1-induced apoptosis through retroviral expression of an antisense cDNA library Nucleic Acids Res., May 16, 2005; 33(9): 2813 - 2821. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |